Avekshan is a Florida company in the business of discovering, developing and marketing novel treatments for ADHD and related disabilities. The first of these treatments is a non-narcotic, non-addictive and non-abusable treatment for ADHD.
Through extensive research and laboratory tests, Avekshan is building an intellectual property base and pipeline for sustained growth and productivity.
Our network of strategic partners ensures that we have all the necessary resources to make the best product on the market. Partnering with academic medical centers and key opinion leaders in the healthcare industry ensures the highest standards of research based on real world feedback at every stage of drug development.
The stringent codes and regulations we have followed to be a GLP qualified lab ensure that our work is performed in accordance with the latest industry regulations.